ICLA Stock Overview
Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells in Sweden, Europe, North America, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Cell Impact AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr0.005 |
| 52 Week High | kr0.72 |
| 52 Week Low | kr0.003 |
| Beta | 1.05 |
| 1 Month Change | 31.58% |
| 3 Month Change | 21.95% |
| 1 Year Change | -99.25% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| ICLA | DE Machinery | DE Market | |
|---|---|---|---|
| 7D | -72.2% | 1.3% | 2.5% |
| 1Y | -99.3% | 23.1% | 5.4% |
Return vs Industry: ICLA underperformed the German Machinery industry which returned 22.8% over the past year.
Return vs Market: ICLA underperformed the German Market which returned 4.6% over the past year.
Price Volatility
| ICLA volatility | |
|---|---|
| ICLA Average Weekly Movement | 188.4% |
| Machinery Industry Average Movement | 4.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.5% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ICLA's share price has been volatile over the past 3 months.
Volatility Over Time: ICLA's weekly volatility has increased from 107% to 188% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 80 | Daniel Vallin | www.cellimpact.com |
Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells in Sweden, Europe, North America, Asia, and internationally. The company offers plates with and precise flow patterns. It serves hydrogen fuel cells producers.
Cell Impact AB (publ) Fundamentals Summary
| ICLA fundamental statistics | |
|---|---|
| Market cap | €8.43m |
| Earnings (TTM) | -€10.38m |
| Revenue (TTM) | €4.07m |
2.1x
P/S Ratio-0.8x
P/E RatioIs ICLA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ICLA income statement (TTM) | |
|---|---|
| Revenue | kr47.66m |
| Cost of Revenue | kr21.81m |
| Gross Profit | kr25.85m |
| Other Expenses | kr147.26m |
| Earnings | -kr121.40m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | 54.24% |
| Net Profit Margin | -254.71% |
| Debt/Equity Ratio | 7.9% |
How did ICLA perform over the long term?
See historical performance and comparison